IBDEI2UZ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45602,2)
 ;;=^5019209
 ;;^UTILITY(U,$J,358.3,45603,0)
 ;;=R09.1^^172^2273^39
 ;;^UTILITY(U,$J,358.3,45603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45603,1,3,0)
 ;;=3^Pleurisy
 ;;^UTILITY(U,$J,358.3,45603,1,4,0)
 ;;=4^R09.1
 ;;^UTILITY(U,$J,358.3,45603,2)
 ;;=^95428
 ;;^UTILITY(U,$J,358.3,45604,0)
 ;;=Z95.1^^172^2273^43
 ;;^UTILITY(U,$J,358.3,45604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45604,1,3,0)
 ;;=3^Presence of aortocoronary bypass graft
 ;;^UTILITY(U,$J,358.3,45604,1,4,0)
 ;;=4^Z95.1
 ;;^UTILITY(U,$J,358.3,45604,2)
 ;;=^5063669
 ;;^UTILITY(U,$J,358.3,45605,0)
 ;;=Z95.3^^172^2273^44
 ;;^UTILITY(U,$J,358.3,45605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45605,1,3,0)
 ;;=3^Presence of xenogenic heart valve
 ;;^UTILITY(U,$J,358.3,45605,1,4,0)
 ;;=4^Z95.3
 ;;^UTILITY(U,$J,358.3,45605,2)
 ;;=^5063671
 ;;^UTILITY(U,$J,358.3,45606,0)
 ;;=R21.^^172^2273^46
 ;;^UTILITY(U,$J,358.3,45606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45606,1,3,0)
 ;;=3^Rash & oth nonspecific skin eruption
 ;;^UTILITY(U,$J,358.3,45606,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,45606,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,45607,0)
 ;;=Z12.9^^172^2273^47
 ;;^UTILITY(U,$J,358.3,45607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45607,1,3,0)
 ;;=3^Screening malig neop site unspec
 ;;^UTILITY(U,$J,358.3,45607,1,4,0)
 ;;=4^Z12.9
 ;;^UTILITY(U,$J,358.3,45607,2)
 ;;=^5062698
 ;;^UTILITY(U,$J,358.3,45608,0)
 ;;=R06.02^^172^2273^48
 ;;^UTILITY(U,$J,358.3,45608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45608,1,3,0)
 ;;=3^Shortness of breath
 ;;^UTILITY(U,$J,358.3,45608,1,4,0)
 ;;=4^R06.02
 ;;^UTILITY(U,$J,358.3,45608,2)
 ;;=^5019181
 ;;^UTILITY(U,$J,358.3,45609,0)
 ;;=R00.0^^172^2273^54
 ;;^UTILITY(U,$J,358.3,45609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45609,1,3,0)
 ;;=3^Tachycardia, unspecified
 ;;^UTILITY(U,$J,358.3,45609,1,4,0)
 ;;=4^R00.0
 ;;^UTILITY(U,$J,358.3,45609,2)
 ;;=^5019163
 ;;^UTILITY(U,$J,358.3,45610,0)
 ;;=R32.^^172^2273^56
 ;;^UTILITY(U,$J,358.3,45610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45610,1,3,0)
 ;;=3^Urinary incontinence, unspec
 ;;^UTILITY(U,$J,358.3,45610,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,45610,2)
 ;;=^5019329
 ;;^UTILITY(U,$J,358.3,45611,0)
 ;;=R33.9^^172^2273^57
 ;;^UTILITY(U,$J,358.3,45611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45611,1,3,0)
 ;;=3^Urine retention, unspec
 ;;^UTILITY(U,$J,358.3,45611,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,45611,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,45612,0)
 ;;=R53.1^^172^2273^58
 ;;^UTILITY(U,$J,358.3,45612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45612,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,45612,1,4,0)
 ;;=4^R53.1
 ;;^UTILITY(U,$J,358.3,45612,2)
 ;;=^5019516
 ;;^UTILITY(U,$J,358.3,45613,0)
 ;;=R63.4^^172^2273^59
 ;;^UTILITY(U,$J,358.3,45613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45613,1,3,0)
 ;;=3^Weight loss, abnormal
 ;;^UTILITY(U,$J,358.3,45613,1,4,0)
 ;;=4^R63.4
 ;;^UTILITY(U,$J,358.3,45613,2)
 ;;=^5019542
 ;;^UTILITY(U,$J,358.3,45614,0)
 ;;=B18.2^^172^2273^28
 ;;^UTILITY(U,$J,358.3,45614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45614,1,3,0)
 ;;=3^Hepatitis C Carrier,Viral
 ;;^UTILITY(U,$J,358.3,45614,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,45614,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,45615,0)
 ;;=Z98.890^^172^2273^42
 ;;^UTILITY(U,$J,358.3,45615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45615,1,3,0)
 ;;=3^Postprocedural States,Other Specified
